Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23153449 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV-F Particle Vaccine;   Biological: Placebo

Indicates status has not been verified in more than two years